chr19-1108530-G-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_014963.3(SBNO2):c.3791C>T(p.Pro1264Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000886 in 1,219,544 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000080 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000090 ( 0 hom. )
Consequence
SBNO2
NM_014963.3 missense
NM_014963.3 missense
Scores
2
1
15
Clinical Significance
Conservation
PhyloP100: 3.71
Genes affected
SBNO2 (HGNC:29158): (strawberry notch homolog 2) Predicted to enable chromatin DNA binding activity and histone binding activity. Involved in several processes, including cellular response to interleukin-6; macrophage activation involved in immune response; and negative regulation of transcription, DNA-templated. Predicted to be active in nucleus. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.25831625).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SBNO2 | NM_014963.3 | c.3791C>T | p.Pro1264Leu | missense_variant | 32/32 | ENST00000361757.8 | NP_055778.2 | |
SBNO2 | NM_001100122.2 | c.3620C>T | p.Pro1207Leu | missense_variant | 29/29 | NP_001093592.1 | ||
SBNO2 | XM_047438466.1 | c.2594C>T | p.Pro865Leu | missense_variant | 29/29 | XP_047294422.1 | ||
SBNO2 | XM_011527804.4 | c.*121C>T | 3_prime_UTR_variant | 32/32 | XP_011526106.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SBNO2 | ENST00000361757.8 | c.3791C>T | p.Pro1264Leu | missense_variant | 32/32 | 1 | NM_014963.3 | ENSP00000354733.2 | ||
SBNO2 | ENST00000587024.5 | c.3761C>T | p.Pro1254Leu | missense_variant | 32/32 | 2 | ENSP00000468520.1 | |||
SBNO2 | ENST00000438103.6 | c.3620C>T | p.Pro1207Leu | missense_variant | 29/29 | 2 | ENSP00000400762.1 | |||
SBNO2 | ENST00000587673.5 | n.*35C>T | downstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.0000801 AC: 12AN: 149852Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
12
AN:
149852
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0000898 AC: 96AN: 1069584Hom.: 0 Cov.: 34 AF XY: 0.0000941 AC XY: 48AN XY: 510302
GnomAD4 exome
AF:
AC:
96
AN:
1069584
Hom.:
Cov.:
34
AF XY:
AC XY:
48
AN XY:
510302
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000800 AC: 12AN: 149960Hom.: 0 Cov.: 33 AF XY: 0.0000956 AC XY: 7AN XY: 73202
GnomAD4 genome
AF:
AC:
12
AN:
149960
Hom.:
Cov.:
33
AF XY:
AC XY:
7
AN XY:
73202
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 12, 2024 | The c.3791C>T (p.P1264L) alteration is located in exon 32 (coding exon 31) of the SBNO2 gene. This alteration results from a C to T substitution at nucleotide position 3791, causing the proline (P) at amino acid position 1264 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;N;.
REVEL
Benign
Sift
Benign
T;T;.
Sift4G
Benign
T;T;T
Polyphen
D;D;.
Vest4
MutPred
Loss of catalytic residue at P1263 (P = 0.016);.;.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at